Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
View Full LandscapeTarget Indication
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Clinical Trial
NCT02296125Last updated: 2/13/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.